NASDAQ:TOI
The Oncology Institute of Hope and Innovation
- Stock
Last Close
3.81
06/11 22:30
Market Cap
34.62M
Beta: 0.88
Volume Today
1.03M
Avg: 176.28K
PE Ratio
−2.13
PFCF: −3.03
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | 4.12M - | 5.40M 30.92% | 7.85M 45.47% | ||||
average payables | 10.76M - | 14.10M 31.00% | 12.47M 11.60% | ||||
average receivables | 16.00M - | 19.25M 20.35% | 30.88M 60.42% | ||||
book value per share | 0.66 - | 0.44 33.44% | 1.57 260.67% | 1.71 8.91% | |||
capex per share | -0.02 - | -0.02 22.79% | -0.02 0.87% | -0.05 148.29% | -0.08 65.10% | -0.06 18.47% | |
capex to depreciation | -0.63 - | -0.41 35.13% | -0.38 8.22% | -0.91 142.69% | -1.25 37.44% | -0.78 37.96% | |
capex to operating cash flow | -0.12 - | -0.33 170.10% | -2.35 605.16% | 0.09 103.97% | 0.09 3.98% | 0.13 40.47% | |
capex to revenue | -0.01 - | -0.01 26.03% | -0.01 17.84% | -0.02 135.70% | -0.02 45.90% | -0.01 35.68% | |
cash per share | 0.04 - | 0.09 145.18% | 1.73 1,754.43% | 1.01 41.25% | |||
days of inventory on hand | 11.31 - | 10.55 6.75% | 14.49 37.35% | 16.87 16.40% | |||
days payables outstanding | 25.85 - | 30.63 18.51% | 35.02 14.32% | 17.07 51.26% | |||
days sales outstanding | 34.61 - | 33.59 2.93% | 38.20 13.70% | 58.58 53.36% | |||
debt to assets | 0.18 - | 0.00 99.50% | 0.41 45,496.89% | ||||
debt to equity | 0.42 - | 0.00 99.59% | 0.87 49,284.64% | ||||
dividend yield | 0.03 - | ||||||
earnings yield | 0.01 - | -0.01 145.44% | -0.02 219.85% | -0.02 17.76% | 0.01 181.53% | -0.55 4,102.24% | |
enterprise value | 622.68M - | 701.95M 12.73% | 531.63M 24.26% | 214.28M 59.69% | |||
enterprise value over ebitda | 2.03K - | -62.18 103.07% | -12.82 79.38% | -3.19 75.09% | |||
ev to operating cash flow | 172.24 - | 1.38K 701.88% | -16.27 101.18% | -3.47 78.67% | |||
ev to sales | 4.01 - | 3.74 6.57% | 2.62 30.04% | 0.85 67.59% | |||
free cash flow per share | 0.17 - | 0.04 78.26% | -0.01 128.45% | -0.54 4,968.59% | -0.92 71.35% | -0.55 40.03% | |
free cash flow yield | 0.02 - | 0.00 78.26% | -0.00 125.55% | -0.06 5,514.44% | -0.56 912.53% | -0.27 51.49% | |
graham net net | -0.03 - | -0.26 786.89% | 0.52 301.90% | -0.42 180.52% | |||
graham number | 0.96 - | 1.48 53.96% | 2.42 63.64% | 0.94 61.24% | |||
income quality | 1.43 - | -0.90 162.91% | -0.04 96.05% | 2.99 8,527.40% | -37.27 1,346.16% | 0.44 101.17% | |
intangibles to total assets | 0 - | 0.61 Infinity% | 0.51 15.26% | 0.22 57.06% | 0.16 28.88% | 0 100% | |
interest coverage | 3.01K - | -780.67 125.95% | -23.62 96.97% | -143.31 506.84% | -17.64 87.69% | -11.36 35.58% | |
interest debt per share | 0.00 - | 0.19 363,634.99% | 0.01 96.01% | 1.54 20,206.13% | |||
inventory turnover | 32.26 - | 34.60 7.23% | 25.19 27.19% | 21.64 14.09% | |||
invested capital | 0.42 - | 0.00 99.59% | 0.87 49,284.64% | ||||
market cap | 278.88M - | 625.13M 124.16% | 696.02M 11.34% | 645.75M 7.22% | 120.11M 81.40% | 150.45M 25.26% | |
net current asset value | 4.49M - | -7.87M 275.06% | 54.78M 796.23% | -8.56M 115.63% | |||
net debt to ebitda | -7.97 - | -0.53 93.40% | 2.75 623.74% | -1.40 151.00% | |||
net income per share | 0.14 - | -0.06 145.44% | -0.22 256.13% | -0.16 25.76% | 0.02 113.80% | -1.13 5,048.23% | |
operating cash flow per share | 0.20 - | 0.06 71.41% | 0.01 85.94% | -0.49 6,356.82% | -0.85 71.93% | -0.49 41.96% | |
payables turnover | 14.12 - | 11.91 15.62% | 10.42 12.53% | 21.38 105.16% | |||
receivables turnover | 10.55 - | 10.87 3.01% | 9.56 12.05% | 6.23 34.79% | |||
research and ddevelopement to revenue | |||||||
return on tangible assets | -0.17 - | -0.45 161.32% | -0.07 84.63% | 0.01 110.81% | |||
revenue per share | 3.94 - | 2.41 38.74% | 2.91 20.66% | 3.07 5.34% | 3.47 13.16% | 4.40 26.76% | |
roe | -0.10 - | -0.51 435.08% | -0.10 79.41% | 0.01 112.67% | |||
roic | -0.10 - | -0.20 108.08% | -0.41 109.20% | -0.24 41.89% | |||
sales general and administrative to revenue | 0.00 - | ||||||
shareholders equity per share | 0.66 - | 0.44 33.44% | 1.57 260.67% | 1.71 8.91% | |||
stock based compensation to revenue | 0.00 - | 0.00 32.94% | 0.12 14,928.96% | 0.11 9.28% | 0.05 49.90% | ||
tangible asset value | 6.14M - | -5.64M 191.82% | 59.29M 1,151.07% | 83.31M 40.52% | |||
tangible book value per share | 0.10 - | -0.09 191.82% | 0.90 1,122.75% | 1.14 27.85% | |||
working capital | 8.21M - | 1.11M 86.44% | 124.26M 11,066.92% | 100.65M 19.00% |
All numbers in USD (except ratios and percentages)